crucial updates on fatty liver disease - easl 2023 - steatotic liver disease, masld, and metald
Published 1 year ago • 1.3K plays • Length 8:08Download video MP4
Download video MP3
Similar videos
-
8:07
fatty liver (nafld) & “new” liver conditions | masld, metald & others (diagnostic criteria)
-
44:23
easl studio midday talks: steatotic liver disease global consensus to change nomenclature
-
58:44
nafld is now masld: what’s new in 2023
-
1:31:27
multi-society and multi-stakeholder consensus revision of the nafld nomenclature: the final results
-
41:05
easl studio s4e12 - nafld and nash – moving beyond the liver biopsy – where are we now?
-
33:10
easl studio s4e20 - cost actions: opportunities for pan-european collaborations in liver diseases
-
4:24
nonalcoholic fatty liver disease (nafld)
-
31:42
easl studio - s3e7 - bugs and the liver — the role of the gut microbiome in liver diseases
-
3:27
together for better liver health: mobilising action for fatty liver disease
-
32:19
easl studio s5e5 - jhep live: the new nomenclature for sld
-
57:46
webinar: easl update - fibroscan applications in nafld-nash
-
0:59
impressions from the liver cancer summit 2023
-
0:51
easl studio s5e2 promo: a critical view on steatotic liver disease and care pathways
-
0:57
easl studio at easl congress 2024 - exploring new frontiers: the ai liver taskforce initiative
-
1:47
s4e22 promo - jhep live: new and promising drugs for nash on the horizon
-
1:22
easl studio s5e01 promo - jhep live: what is really new in the easl cpg on aclf?
-
29:25
easl studio special episode “promoting liver health: an urgent call for action at who”
-
1:47
elevation of liver enzymes
-
2:00
reducing the burden of alcohol-related liver disease (arld)